Latest News

Cancer drugs block dementia-linked brain inflammation, study finds

A class of drugs developed to treat immune-related conditions and cancer -- including one currently in clinical trials for glioblastoma and other tumors -- eliminates neural inflammation associated with dementia-linked diseases and brain injuries, according to researchers. In their study, the researchers discovered that the drugs, which can be delivered orally, eradicated microglia, the primary immune cells of the brain. These cells exacerbate many neural diseases, including Alzheimer's and Parkinson's, as well as brain injury.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • One out of three severely injured patients undertriaged in the United States

  • Food memory: Discovery shows how we remember taste experiences

  • Brainwave test could improve autism diagnosis, classification

  • Benefits of wellness program for people with multiple sclerosis demonstrated in pilot study

  • Physical activity in older adults linked to brain white-matter integrity

  • Researchers discover how circular RNA is created, find link to degenerative disease

  • Providing private mental health service to veterans: Hurdles, challenges, advice

  • Cooling of dialysis fluids protects against brain damage

  • Mycotoxin present in many types of food deteriorates neuroregeneration

  • Mitochondria's role in neurodegenerative diseases clearer thanks to mouse study

  •